NEW YORK (360Dx) – Spanish diagnostics firm Bioprognos announced yesterday that it has received CE marking for MBDAA for Lung Neoplasia Dx — an algorithm used in the diagnosis of lung cancer — clearing it for sale in the European Union.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.